FFA
AGIO icon

Farther Finance Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Farther Finance Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14K Sell
422
-62
-13% -$2.17K ﹤0.01% 4417
2026
Q2 		$18.1K Buy
484
+282
+140% +$8.55K ﹤0.01% 4050
2026
Q1 		$6.91K Buy
202
+51
+34% +$1.45K ﹤0.01% 4329
2025
Q4 		$4.11K Sell
151
-10
-6% -$351 ﹤0.01% 4409
2025
Q3 		$6.46K Buy
161
+10
+7% +$376 ﹤0.01% 3655
2025
Q2 		$5.02K Buy
151
+139
+1,158% +$4.21K ﹤0.01% 3357
2025
Q1 		$329 Sell
12
-6
-33% -$199 ﹤0.01% 3854
2024
Q4 		$591 Sell
18
-1
-5% -$47 ﹤0.01% 3411
2024
Q3 		$848 Buy
19
+3
+19% +$136 ﹤0.01% 3287
2024
Q2 		$694 Buy
16
+5
+45% +$180 ﹤0.01% 3187
2024
Q1 		$317 Sell
11
-36
-77% -$964 ﹤0.01% 3154
2023
Q4 		$1.05K Buy
+47
New +$1.05K ﹤0.01% 2706

Other funds holding AGIO

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BWM
Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return

Farther Finance Advisors's AGIO Position: Q3 2026 in Review

Farther Finance Advisors reduced its Agios Pharmaceuticals (AGIO) stake by 13% in Q3 2026, selling an estimated $2.17K and leaving 422 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #4417.

Farther Finance Advisors first reported a position in AGIO in Q4 2023 and has held it in 12 quarters since. The position peaked at $18.1K in Q2 2026. 4 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Farther Finance Advisors held 422 shares of Agios Pharmaceuticals worth $14K as of Q3 2026.
  • Farther Finance Advisors sold 62 Agios Pharmaceuticals shares in Q3 2026, an estimated $2.17K.
  • Agios Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4417 holding.
  • Farther Finance Advisors first reported a position in Agios Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Agios Pharmaceuticals position peaked at $18.1K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.